Kidney involvement in patients with coronavirus disease 2019 (COVID-19) is common, and
can range from the presence of proteinuria and haematuria to acute kidney injury (AKI) …

Introduction Little is known of the clinical outcomes of secondary oxalate nephropathy. To
inform clinical practice, we performed a systematic review of case reports and case series to …

Background There are limited data on acute kidney injury (AKI) progression and long-term
outcomes in critically ill patients with coronavirus disease-19 (COVID-19). We aimed to …

Background Immune checkpoint inhibitor-associated acute kidney injury (ICPi-AKI) has emerged
as an important toxicity among patients with cancer. Methods We collected data on 429 …

Background: Using movies has been accepted worldwide as a tool to help students learn
medical professionalism. In the second year, a group of medical students conducted the “…

Background The timing of renal replacement therapy (RRT) for severe acute kidney injury is
highly debated when no life-threatening complications are present. We assessed whether a …

Background The timing of initiation of renal replacement therapy (RRT) in severe acute kidney
injury (AKI) remains controversial, with early initiation resulting in unnecessary therapy for …

Background Acute kidney injury (AKI) is common in critically ill patients with coronavirus
disease-19 (COVID-19). We aimed to explore the changes in AKI epidemiology between the first …

We aimed to determine whether urinary neutrophil gelatinase-associated lipocalin (uNGAL)
can accurately predict persistent AKI, major adverse kidney events at 30 days (MAKE30) …

Background When severe, COVID-19 shares many clinical features with bacterial sepsis. Yet,
secondary bacterial infection is uncommon. However, as epithelium is injured and barrier …